Evidence map›Paper›PMID 35247152›Full record

ReviewQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2022

Capturing what matters: updating NICE methods guidance on measuring and valuing health.

Dalia Dawoud, Alan Lamb, Alan Moore, Caroline Bregman, Ewa Rupniewska, Thomas Paling, Verena Wolfram, Rosemary E S Lovett, Ross Dent

Abstract readReview
In one paragraph

Review in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Mapping of Family Reported Outcome Measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Trial
  4. Mapping PedsQL™ scores to CHU9D utility weights for children with chronic conditions in a multi-ethnic and deprived metropolitan population.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. The psychometric performance of the EQ-HWB-9 for measuring health and wellbeing in a general population sample from Australia and New Zealand.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The performance of the EQ-HWB-S as a measure of quality-of-life of caregivers in families that have experienced adverse events.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dalia DawoudNational Institute for Health and Care Excellence (NICE), Manchester, UK. dalia.dawoud@nice.org.uk.ORCID http://orcid.org/0000-0002-2105-1937
Alan LambNational Institute for Health and Care Excellence (NICE), Manchester, UK.
Alan MooreNational Institute for Health and Care Excellence (NICE), Manchester, UK.
Caroline BregmanNational Institute for Health and Care Excellence (NICE), Manchester, UK.
Ewa RupniewskaNational Institute for Health and Care Excellence (NICE), Manchester, UK.
Thomas PalingNational Institute for Health and Care Excellence (NICE), Manchester, UK.
Verena WolframNational Institute for Health and Care Excellence (NICE), Manchester, UK.
Rosemary E S LovettNHS England and NHS Improvement, Medicines Repurposing Program, London, UK.
Ross DentNational Institute for Health and Care Excellence (NICE), Manchester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In July 2019, the National Institute for Health and Care Excellence (NICE) initiated a major review of its health technology evaluation methods to update its methods guide. This update has recently concluded with the publication of its health technology evaluation manual in January 2022. This paper reports the methods and findings of the review in relation to the recommended approach to use for the measurement and valuation of health-related quality of life (HRQoL) in submissions to NICE. Issues related to (i) the methods to use when NICE's preferred measure (EQ-5D) is not appropriate or not available; (ii) adjusting health state utility values over time to account for age; (iii) measuring and valuing HRQoL in children and young people; and (iv) including carers' QoL in economic evaluations were included in this review. This commentary summarises the methods used to undertake the review, its findings, and the changes to NICE methods that were proposed based on these findings. It also outlines topics where further research is needed before definitive methods guidance can be issued. The broad proposals described here were subject to a public consultation in 2020 and a further consultation on the updated methods guidance was completed in October 2021 before the publication of the manual in January 2022.

Indexed as

CaregiversQuality of LifeAdolescentChildCost-Benefit AnalysisHumansTechnology Assessment, BiomedicalAge-adjustmentCarerChildrenHealth-related quality of lifeHealth technology assessmentUtilities

Identifiers

PMID35247152
PMCPMC9188493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.